Pleiotropic Effects of Statins on the Cardiovascular System

Oesterle, Adam, Laufs, Ulrich, Liao, James K.·2017·Circulation Research

Cited by (1,000)

Items 801–900 of 1,000

  1. The Effect of Atorvastatin on Lipid Profile and Inflammatory Marker in patient with Diabetes Dyslipidemia
    Rezlie Bellatasie, Suharjono Suharjono, Wiwid Samsulhadi, Nur Palestin Ayumuyas · 2022 · Research Journal of Pharmacy and Technology
  2. Rosuvastatin relaxes rat thoracic aorta, pulmonary artery, and trachea via nitric oxide, prostanoids, and potassium channels
    Serdar Şahintürk · 2023 · Çukurova medical journal (Online)/Çukurova medical journal
  3. Association between the Use of Statins and Brain Tumors
    Sarang Jang, Hyo Geun Choi, Mi Jung Kwon, Ji Hee Kim, Joo‐Hee Kim, So Young Kim · 2023 · Biomedicines
  4. Drug-based approaches to modulate mitochondrial condition in the case of atherosclerosis: focus on correction of mitochondria dysfunction
    Darina Gavrilova, Evgeny E. Bezsonov, Tatyana Degtyarevskaya · 2023 · Journal of Translational Genetics and Genomics
  5. Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study
    Carlotta Franchi, Raffaella Rossio, Sara Mandelli, Ilaria Ardoino, Alessandro Nobili, Flora Peyvandi, Pier Mannuccio Mannucci, REPOSI Investigators, Pier Mannuccio Mannucci, Alessandro Nobili et al. · 2024 · Internal and Emergency Medicine
  6. Small GTP-binding protein GDP dissociation stimulator influences cisplatin-induced acute kidney injury via PERK-dependent ER stress
    Yuxue Yang, Ting Xiong, Wang Ti, Xiwei Chen, Ziwei Ma, Bangyun Zuo, Ning Dong, Ruilong Song, Xuesong Liu, Daxin Wang · 2024 · Communications Biology
  7. The Impact of Atorvastatin Treatment on the Distribution of Low-Density Lipoprotein Subfractions and the Level of Vitamin D in Patients After Acute Myocardial Infarction: Preliminary Findings
    Grażyna Sygitowicz, Dariusz Sitkiewicz, Karol Wrzosek, Mirosław Dłużniewski · 2024 · International Journal of Molecular Sciences
  8. Metformin Attenuates Myocardial Ischemia-Reperfusion Injury through the AMPK-HMGCR-ROS Signaling Axis
    He Zhu, Tao Zhu, Dubiao Dubiao, Xinmei Zhang · 2024 · Kardiologiia
  9. KLF2-dependent transcriptional regulation safeguards the heart against pathological hypertrophy
    Yongqi Wu, Yujuan Song, Nan Xie, Wanqing Zhao, Jian Lv, Tingting Zhang, Yang Zhang, Hongyin Chen, Weiyun Sun, Zhenyu Luo et al. · 2024 · Journal of Molecular and Cellular Cardiology
  10. Atypical antipsychotics impair the lipid-lowering and pleiotropic effects of simvastatin via activation of the ADMA-NOX-ROS pathway
    Chia-Hui Chen, Wen‐Hua Chen, Chiao‐Po Hsu, Tzong‐Shyuan Lee · 2025 · Biomedicine & Pharmacotherapy
  11. Exploring the connection between dementia and cardiovascular risk with a focus on ADAM10
    Ana Beatriz Aparecida Targas, Pedro Henrique Moreira Victoriano, Mateus Balleiro Bertoldo Garcia, Vanessa Alexandre-Silva, Márcia R. Cominetti · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  12. Therapeutic Management of LDL-C: Efficacy and Economic Impact Assessment
    Abdallah Elshafeey · 2025 · Journal of Cardiovascular Development and Disease
  13. Donor Simvastatin Treatment in Heart Transplantation: 5-y Results of SIMVA Trial
    Emil J. Holmström, Simo O. Syrjälä, Kishor Dhaygude, R. Krebs, Ilkka Helanterä, Jyri Lommi, Antti I. Nykänen, Karl Lemström · 2025 · Transplantation
  14. Therapeutic effects of rosuvastatin in hypercholesterolemic prediabetic mice in the absence of low density lipoprotein receptor
    Erika Gurzeler, Einari Aavik, Anssi Laine, Teemu Valkama, Henri Niskanen, Jenni Huusko, Minna Unelma Kaikkonen, Seppo Ylä‐Herttuala · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
  15. The Impact of Atorvastatin on Cardiac Performance for Dilated Cardiomyopathy: A Meta-analysis of Randomized Controlled Studies
    Лин Фу, Xiaoyang Shang, Xiaoshan Zhang · 2020 · The Heart Surgery Forum
  16. LDL (Low-Density Lipoprotein) Cholesterol Below 70
    Matthias Endres, Walter N. Kernan · 2020 · Stroke
  17. Medical management of a suspected atrial myxoma in a nonagenarian
    Jessica Kawall, Rajeev Virender Seecheran, Valmiki Krishna Seecheran, Sangeeta Anjali Persad, Stefan Maharaj, Naveen Anand Seecheran · 2020 · SAGE Open Medical Case Reports
  18. ATORVASTATIN AMELIORATES CISPLATIN INDUCED OXIDATIVE STRESS IN EHRLICH ASCITES SOLID TUMOR-BEARING MICE: A PROSPECTIVE CASE CONTROL STUDY
    Ola Sayed M. Ali, Noha Abdel-Rahman Eldesoky, Ahmad Muhammad Salahuddin, Nehal Mohamed Eisa · 2018 · Al-Azhar Medical Journal
  19. The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
    Robert G. Krysiak, Karolina Ewa Kowalcze, Bogusław Okopień · 2021 · Coronary Artery Disease
  20. Determinants of the Survival Benefit Associated with Statins in Patients with Acute Heart Failure
    Chan Soon Park, In‐Chang Hwang, Jin Joo Park, Jun‐Bean Park, Jun‐Bean Park, Goo‐Yeong Cho · 2021 · ESC Heart Failure
  21. MANAGEMENT OF PATIENTS WITH DYSLIPIDEMIA IN THE PRACTICE OF FAMILY MEDICINE
    Nestor M. Seredyuk, Vitaliy Seredyuk, Р. В. Деніна, P.P. Zvonar, M.V. Bielinskyi, Z. S. Andriitsiv · 2021 · Art of Medicine
  22. Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine
    Arnoud van der Laarse, Christa M. Cobbaert · 2021 · Expert Review of Cardiovascular Therapy
  23. The Role of Statins in Prevention of Cardiovascular Diseases in Real Clinical Practice
    Karpov IuA, Moscow, Russian Federation · 2021 · Doctor Ru
  24. Mir-485-5p on the Morphology and Function of Cardiovascular System
    Delai Zhang, Qian Nie, Yanru Liu, Zaoying Li, Wen Xie, Li Jiang · 2022 · Cellular and Molecular Biology
  25. The impact of a comprehensive pharmaceutical care intervention in addition to cardiac rehabilitation program on outcomes of post-acute coronary syndrome patients: A pilot study
    Eman Ahmed Casper, Lamia Mohamed El Wakeel, Mohamed Ayman Saleh, Manal El‐Hamamsy · 2022 · Patient Education and Counseling
  26. Dynamic coronary CT Angiography-Estimated coronary flow in Non-Obstructive, Plaque-free coronary Arteries: Association with dyslipidemia and diabetes
    Yukako Izoe, Michinobu Nagao, Kayoko Sato, Akiko Sakai, Kiyoe Ando, Miwa Kanai, Astushi Yamamoto, Shuji Sakai, Koichi Chida · 2022 · IJC Heart & Vasculature
  27. The gut microbiome dysbiosis is recovered by restoring a normal diet in hypercholesterolemic pigs
    Leonie Schoch, Pablo Sutelman, Rosa Suades, Lina Badimón, Isabel Moreno‐Indias, Gemma Vilahur · 2022 · European Journal of Clinical Investigation
  28. Can statins reduce mortality in critically ill COVID-19 patients? A retrospective cohort study
    Heba A. Labib, Rania Magdy Mohamed Ali, Ayman Ibraheem Tharwat · 2023 · Egyptian Journal of Anaesthesia
  29. Pharmacological Action of Atorvastatin and Metformin on Non-alcoholic Fatty Liver Disease on an Experimental Model of Metabolic Syndrome
    Castillo Tomas Augusto, María de la Paz Scribano Parada, Micaela Milagros Rossi, Franco José Signorini, Ismael Bernardo Fonseca, María del Carmen Báez · 2021 · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
  30. RAAS inhibition and beyond—cardiovascular medications in patients at risk of or affected by COVID-19
    Alexander Dutsch, Heribert Schunkert · 2023 · Herz
  31. CLINICAL AND RADIOGRAPHICAL EVALUATION OF THE EFFECT OF USING THREE DIFFERENT DIRECT PULP CAPPING MATERIALS IN PRIMARY MOLARS
    Noran Attia, Ola Abd El-Geleel, Amr Abdelaziz · 2023 · Egyptian Dental Journal /Egyptian Dental Journal
  32. Effect of statin treatment on mortality in elderly patients with type 2 diabetes mellitus patients: a retrospective cohort study
    Yao Fan, Juan Wang, Haidi Wu, Lingli Dai, Lan Wang, Liubao Gu · 2023 · BMC Geriatrics
  33. Lipoprotein(a) in patients with breast cancer after chemotherapy: exploring potential strategies for cardioprotection
    Ziqing Wang, Jian Li · 2023 · Lipids in Health and Disease
  34. Relationship between prior statin therapy and radiological features and clinical outcomes of intracerebral hemorrhage
    Kun He Lee, Filipa Carvalho, Vasileios‐Arsenios Lioutas, Elizabeth C. Heistand, Alvin S. Das, Sarah Marchina, Ashkan Shoamanesh, Aristeidis H. Katsanos, Amjad Shehadah, Diego Incontri Abraham et al. · 2023 · Journal of Stroke and Cerebrovascular Diseases
  35. Early statin exposure influences cardiac and skeletal development with implications for ion channel transcriptomes in zebrafish
    Ying Zhao, Houzhi Yang, Huinan Li, Shuang Liang, Meng Wang, Chundi Li, Donghai Zhuo, Feifei Fan, Miao Guo, Xinxin Lv et al. · 2024 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
  36. Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2
    Hiroshi Mabuchi, Ryusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Nobutaka Ikeda, Yohei Kobayashi, Satoshi Ikeda et al. · 2024 · Journal of Thrombosis and Thrombolysis
  37. Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms
    Luca Di Vito, Federico Di Giusto, Serena Mazzotta, Giancarla Scalone, Filippo Bruscoli, Simona Silenzi, Adelina Selimi, Mario Angelini, Piero Galieni, Pierfrancesco Grossi · 2024 · International Journal of Cardiology
  38. Association of higher potency statin use with risk of osteoporosis and fractures in patients with stroke in a Korean nationwide cohort study
    Jin Sook Jeong, Yunha Noh, Sun Wook Cho, Cheng‐Yang Hsieh, Yongtai Cho, Ju‐Young Shin, Hoon Kim · 2024 · Scientific Reports
  39. Predicting the risk of ischemic stroke in patients with atrial fibrillation using heterogeneous drug–protein–disease network-based deep learning
    Zhiheng Lyu, Jiannan Yang, Zhongzhi Xu, Weilan Wang, Weibin Cheng, Kwok‐Leung Tsui, Qingpeng Zhang · 2025 · APL Bioengineering
  40. Effects of atorvastatin on time-dependent change of fast sodium current in simulated acute ischaemic ventricular myocytes
    Hongshi Li, Zheng Wan, Tianming Teng, Xin Du, Jing Nie · 2019 · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa
  41. The interplay of membrane cholesterol and substrate on vascular smooth muscle biomechanics
    Hanna J. Sanyour, Alex P. Rickel, Zhongkui Hong · 2020 · Current topics in membranes
  42. Molecular mechanisms of the cardiotoxic action of anthracycline antibiotics and statin-induced cytoprotective reactions of cardiomyocytes
    Турсунова Наталья Владимировна, Клинникова Марина Геннадьевна, O. A. Babenko, Elena L. Lushnikova · 2020 · Biomeditsinskaya Khimiya
  43. Pitavastatin stimulates retinal angiogenesis via HMG-CoA reductase-independent activation of RhoA-mediated pathways and focal adhesion
    Zhi Li, Jing Zhang, Yanni Xue, Ying He, Lanlan Tang, Min Ke, Yan Qing Gong · 2021 · Graefe s Archive for Clinical and Experimental Ophthalmology
  44. Pharmacogenomics of Blood Lipid Regulation
    Marc‐André Legault, Jean‐Claude Tardif, Marie‐Pierre Dubé · 2018 · Pharmacogenomics
  45. Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19
    Elena Izkhakov, Yair Vilian, Assaf Buch, Veronika Denysov, Dima Namouz, Alexandra Nathan, Yona Greenman, Tomer Ziv‐Baran · 2023 · BMC Geriatrics
  46. microRNAs and Response to Statins in Patients with Hypercholesterolemia: From Basic Research to Precision Medicine
    Tomás Zambrano, Luis Antonio Salazar · 2018 · Pharmacogenomics
  47. The legacy of HOPE-3
    Eric H. Boersma, Isabella Kardys · 2021 · European Heart Journal
  48. Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG
    Olga Fedorishina, Константин Викторович Протасов, A. M. Torunova · 2020 · Rational Pharmacotherapy in Cardiology
  49. Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
    Marta Di Simone, Anna Maria Corsale, Elena Lo Presti, Nicola Scichilone, Carmela Picone, Lydia Giannitrapani, Francesco Dieli, Serena Meraviglia · 2022 · Cells
  50. Role of Statins after Endovascular Repair of Abdominal Aortic Aneurysms: A Nationwide Population-Based Study
    Gyu Chul Oh, Kwan Yong Lee, Eun Ho Choo, Byung‐Hee Hwang, Wook Sung Chung, So-Jeong You, JinKyung Jeon, Sol Kwon, Kiyuk Chang · 2023 · Journal of Clinical Medicine
  51. Relationship between lipid profile and B‑type natriuretic peptide T‑381C (rs198389) gene polymorphism in patients with stable coronary artery disease
    Gawhar Ahmed Shekha, Kalthum Asaaf Maulood, Mudhir Sabir Shekha · 2023 · Cellular and Molecular Biology
  52. The nonlinear relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol and the risk of diabetic kidney disease in patients with type 2 diabetes mellitus
    D. Cai, Ye-Hong Huang, Ni-Na Lin, Yunfeng Zhang, Shu-Qin Huang, Yun Han, Xin-Yu Hu, Song-Tao Cai, Yan-Ling Tao · 2025 · Frontiers in Medicine
  53. Pharmacist-Initiated Team-Based Intervention for Optimizing Guideline-Directed Lipid Therapy of Hospitalized Patients With Acute Coronary Syndrome: Pilot Study Using a Stepped-Wedge Cluster Design
    Gayle L. Flo, Mateo Alzate Aguirre, Benjamin R. Gochanour, Kristin J Hynes, Christopher G. Scott, Angela L Fink, Adelaide Maria Arruda-Olson · 2025 · JMIR Cardio
  54. Development of an LC-MS method for the determination of simvastatin and its hydroxy acid form in muscle tissue and method application
    Ewa Paszkowska, Karolina Pietrowska, Steen Larsen, Emilia Fornal, Michał Ciborowski · 2025 · PLoS ONE
  55. Cardiotropic ligand-guided liposomes for myocardial delivery of atorvastatin in a mouse model of myocardial infarction
    Venkateswararao Eeda, Andria F. Hedrick, Atul Pranay, Kenneth Michael Humphries, Evan Heidenreich, Vibhudutta Awasthi · 2025 · International Journal of Pharmaceutics
  56. Interplay of kidney function and anti-SARS-CoV-2 antibodies in COVID-19 mortality: a prospective cohort study
    Sylvia Mink, Heinz Drexel, Andreas Leiherer, Janne Cadamuro, Wolfgang Hitzl, Emanuel Zitt, Matthias Frick, Patrick Reimann, Christoph H. Saely, Peter Fraunberger · 2025 · Scientific Reports
  57. Repurposing a Lipid-Lowering Agent to Inhibit TNBC Growth Through Cell Cycle Arrest
    Yi‐Chiang Hsu, Kuan-Ting Lee, Sung‐Nan Pei, Kun-Ming Rau, Tai‐Hsin Tsai · 2025 · Current Issues in Molecular Biology
  58. Research advances in protein prenylation in cardiovascular diseases
    Wen Shi, Yuxiao Chen, Xuan Zhang, Lian Lou, Pengli Wang, Rong Jiang, Shuo Liu, Thida Sok, Qi Zhang, Xiaogang Guo et al. · 2025 · European Journal of Pharmacology
  59. A hierarchical MgF2/polyurethane/pitavastatin coating alleviates degradation and enhances endothelialization of bioresorbable magnesium alloy stents
    Zhenglong Dou, Yan Fu, Shuiling Chen, Manfred F. Maitz, Wengtai Zhang, Keyun Li, Jingcheng Zheng, Zhen Zhang, Nan Huang, Zhilu Yang · 2025 · Bioactive Materials
  60. Evolving Cardioprotective Strategies in Cardio-Oncology: A Narrative Review
    Elena Wadden, Sanjay Amrith Chandrasekhar, Timothy Jordan, Andrea Diaz, Marta Alhama-Belotto, Efstathia Andrikopoulou, Douglas J. Leedy, Alexi L. Vasbinder, Richard Kar-Hang Cheng · 2025 · Current Cardiology Reports
  61. Lipopolysaccharide stimulates dynamic changes in B cell metabolism to promote proliferation
    Dana M.S. Cheung, Momchil Razsolkov, Fabrizia Bonacina, Stephen Andrews, Megan Sumoreeah, Linda V. Sinclair, Andrew J.M. Howden, J. Simon C. Arthur · 2026 · eLife
  62. Targeted delivery of calcium antagonist by side-chain selenium containing polymer for cardiac hypertrophy therapy
    Shaodong Zhai, Nan Hu, Zhenghao Wang, Hongnv Zhang, Xiang Guo, Ruiping Zhang · 2025 · Colloids and Surfaces B Biointerfaces
  63. Gut microbiota profiles by LDL-C target achievement in statin-treated patients: A cross-sectional study
    Yi‐Hsueh Liu, Po Peng, Wei‐Chun Hung, Ping‐Hsun Wu, Cheng–Yuan Kao, Pei-Yu Wu, Jiun‐Chi Huang, Szu‐Chia Chen, Chao‐Hung Kuo · 2025 · Nutrition Metabolism and Cardiovascular Diseases
  64. Inflammation and Oxidative Stress in Cardiovascular-Kidney-Metabolic Syndrome
    Emilia Valasciuc, Evelina Maria Gosav, Daniela Maria Tănase · 2025 · Springer eBooks
  65. Association of statin use with attenuated radiation-induced intestinal injury and matrix metalloproteinase-9 modulation: Preclinical and clinical evidence
    Sang Sik Cho, Jun Suk Kong, Won Il Jang, Sehwan Shim, Seung Bum Lee, Sunhoo Park, Hyosun Jang · 2026 · Biomedicine & Pharmacotherapy
  66. Combination of cardioprotective glucose-lowering drugs and statins on cardiovascular mortality in diabetes: a nationwide cohort study
    Tummas Ternhamar, Mia Ø Johansen, Børge Grønne Nordestgaard, Shoaib Afzal · 2026 · European Journal of Preventive Cardiology
  67. Therapeutic Strategies for Endothelial Dysfunction in Cardiovascular Disease, Rheumatoid Arthritis, and Diabetes: Current and Emerging Approaches
    Vikrant Verma · 2026 · Cardiovascular & Hematological Agents in Medicinal Chemistry
  68. Deep learning-based early prediction of carotid plaque response to lipid-lowering therapy using longitudinal multimodal ultrasound imaging
    Lulu Jiang, Yaning Sun, Wendi Huang, S H Wang, Danqin Pan, Yanming Zhang, Mengjie Liang · 2026 · Insights into Imaging
  69. Toward metabolic precision medicine in heart failure: Timing, tissue specificity, and network reconstruction
    Li Chen, X Y Yang, Yan Jiang, Shi-Qi Cheng, Zhe Wan, Jin-Wen Wu, Chen M, Y. Li, Gang Luo, Mengnan Liu · 2026 · Life Sciences
  70. Danshen decoction stabilizes vulnerable atherosclerotic plaques by maturating intraplaque neovessels via the Piezo1/yes-associated protein/angiopoietin-1 pathway
    Xiran Guo, Peina Meng, Lei Zhang, Muhan Zhou, Li Y, Qian Liu, Yuan Fang, Xiaojin Xu, K Pei · 2026 · Journal of Ethnopharmacology
  71. Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives
    Seyed Saeed Tamehri Zadeh, Peter Paul Toth, Maciej Banach · 2026 · Frontiers in Pharmacology
  72. Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination
    Ghada A. Badawi, Rehab M. El‐Sayed, Mohamed N Fawzy · 2026 · Inflammopharmacology
  73. Association between timing of statin treatment after diabetes diagnosis and risk of dementia: a nationwide observational study
    Tummas Ternhamar, Mia Ø Johansen, Børge Grønne Nordestgaard, Shoaib Afzal · 2026 · The Lancet Regional Health - Europe
  74. Genetically Mediated Differences in LDL Cholesterol and Risk of Venous Thromboembolism
    Yang Sui, Shinwan Kany, Shaan S. Khurshid, Kelvin Supriami, Joel T Rämö, Sean Joseph Jurgens, Nobuyuki Enzan, Seung Hoan Choi, Zhi Yu, Linke Li et al. · 2026 · Journal of the American College of Cardiology
  75. Pharmacogenetic Implications of Statin Therapy on Oxidative Stress in Coronary Artery Disease
    Nivas Shyamala, Surekha Rani Hanumanth · 2019 · Springer eBooks
  76. Influence of preoperative statins and aspirin administration on biological and magnetic resonance imaging properties in patients with abdominal aortic aneurysm
    Milos M. SLADOJEVIC, Petar Zlatanović, Željka Stanojević, Igor B. KONCAR, Sašenka Vidičević, Jelena Tasić, Aleksandra Isaković, Ivan Tomić, Perica Mutavdžić, Ksenija S. Stevanovic et al. · 2020 · VASA
  77. Механизмы плейотропных эффектов статинов
    Александр Анатольевич Горбунов, Елена Юрьевна Лемина · 2020 · Экспериментальная и клиническая фармакология
  78. Shrinking Weibel‐Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma
    Francesca Patella, Chiara Vendramin, Oscar Charles, Marie Scully, Daniel F. Cutler · 2021 · Research and Practice in Thrombosis and Haemostasis
  79. Association of statin pre-treatment with baseline stroke severity and outcome in patients with acute ischemic stroke and received reperfusion treatment: An observational study
    Irene Escudero‐Martínez, Marius Matusevicius, Ana Paiva Nunes, Petr Ševčík, Miroslava Nevšímalová, Viiu‐Marika Rand, Janika Kõrv, Manuel Cappellari, Robert Mikulík, Danilo Toni et al. · 2022 · International Journal of Stroke
  80. Surrogate Inflammatory Markers and Some Correlates in Pre-dialysis Chronic Kidney Disease Patients: a cross-sectional study
    Manmak Mamven, Ifeanyi Ucha, Oluseyi Ademola Adejumo · 2022 · Babcock University Medical Journal
  81. Mechanisms of Nerve Injury in Diabetes: Dyslipidemia, Bioenergetics, and Oxidative Damage
    Stéphanie Eid, Mohamed H. Noureldein, Masha G. Savelieff, Eva L. Feldman · 2023 · Contemporary diabetes
  82. Statins for women with polycystic ovary syndrome not actively trying to conceive
    Ting Xiong, Éloïse Fraison, Eleni Kolibianaki, Michael Costello, Christos A. Venetis, Elena Kostova · 2023 · Cochrane Database of Systematic Reviews
  83. Preeclampsia pravastatin early VS late treatment: Effects on oxidative stress and vascular reactivity
    Franco A. Ramírez Sanchez, Damián A. Madrigal-Aguilar, Cecilia Tufiño, Seidy Z. Castro-García, Rosa Amalia Bobadilla-Lugo · 2024 · Pregnancy Hypertension
  84. A retrospective study on the effect of statins on mortality and antimicrobial resistance among patients with Staphylococcus aureus bloodstream infection
    Jianwei Su, Yixuan Wang, Wanping Zhong, Mengzhi Wang, Yanhong Wang · 2024 · Archives of Medical Science
  85. The effect of statin treatment on glucose homeostasis in prediabetic individuals: A prospective, randomized, controlled trial
    Wan-Yin Cheng, Li-Hsin Chang, Harn-Shen Chen · 2024 · Journal of the Chinese Medical Association
  86. Statins during Anticoagulation for Emergency Life-Threatening Venous Thromboembolism: A Review
    Carmine Siniscalchi, Egidio Imbalzano, Tiziana Meschi, Andrea Ticinesi, Beatrice Prati, Manuela Basaglia, Giuseppe Camporese, Alessandro Perrella, Andreev Viorica, Elisa Eletto et al. · 2024 · Medicina
  87. Longitudinal cohort study highlights cancer-preventive benefits of lipid-lowering drugs
    Zinuo Yuan, Chunhui Ding, Jingjing Duan, Ruonan Lian, Yingzhou Shi, Junming Han, Hang Dong, Yongfeng Song, Jiajun Zhao, Xiude Fan · 2024 · iScience
  88. Evidence of an effect of statins on lesions originating from dental infection. A retrospective clinical investigation
    Francesca Ideo, Giuseppe Guglielmo Mercuro, Silvia Sanna, Giulia Bardini, Sadia Ambreen Niazi, Francesco Mannocci, Elisabetta Cotti · 2024 · International Journal of Cardiology
  89. Different diabetogenic effect of statins according to intensity and dose in patients with acute myocardial infarction: a nationwide cohort study
    Jieun Lee, Jah Yeon Choi, Byoung Geol Choi, You-Jung Choi, Soohyung Park, Dong Oh Kang, Eun Jin Park, Ji Bak Kim, Seung‐Young Roh, Jin Oh Na et al. · 2024 · Scientific Reports
  90. Fluvastatin suppresses hemin-induced cell death, reactive oxygen species generation, and elevated labile iron pool
    Shion Imoto, Katsuyasu Saigo, Mari Kono, Ayako Ohbuchi, Tohru Sawamura, Yuji Mizokoshi, Takashi Suzuki · 2024 · Hematology Transfusion and Cell Therapy
  91. Optimizing Outcomes in Heart Transplantation: The Role of High‐Intensity Statin Therapy
    Nima Ghavamikia, Hossein Saffarfar, Babak Seifdavati, Mohaddeseh Jamali, Shadi Izadidehkordi, SeyedAbbas Pakmehr, Mohammadreza Aghabali, Negar Jahani, Payam Ali‐Khiavi, Abtin Soleimanian et al. · 2024 · Journal of Biochemical and Molecular Toxicology
  92. Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases
    Federico Biscetti, Giorgia Polito, Maria Margherita Rando, Maria Anna Nicolazzi, Luis H. Eraso, Paul J DiMuzio, Massimo Massetti, Antonio Gasbarrini, Andrea Flex · 2025 · International Journal of Molecular Sciences
  93. The protective effect of coadministration of coenzyme Q10 and vitamin E on myopathy induced by simvastatin in rats
    Omar Ammar Hashim, Intesar Tarik Numan, Nadia Hameed Mohammed · 2025 · Toxicology Reports
  94. Statins boost beneficial pleiotropic cardiovascular effects of cilostazol in angiotensin-II hypertensive rats
    Ahmed Hamdy, Hany M. El‐Bassossy, Shimaa Mustafa Elshazly, Shaimaa S. El-Sayed · 2025 · European Journal of Pharmacology
  95. Differences in inflammation biomarkers between patients with paroxysmal and persistent atrial fibrillation in the femoral vein and coronary sinus blood samples; a cohort study
    Carlos Valera-Soria, Carl‐Johan Carlhäll, Lars Karlsson, Johan Lindbäck, Ziad Hijazi, Emmanouil Charitakis · 2025 · European Heart Journal Open
  96. Pathogenetic rationale for using an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and an antioxidant coenzyme Q10 in the treatment and prevention of cardiovascular disease
    Сергей Гаврилович Дзугкоев, O.Yu. Garmash, Фира Соломоновна Дзугкоева · 2021 · CARDIOVASCULAR THERAPY AND PREVENTION
  97. Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction
    Z Y Liu, Hu Gaopin, Fei Meiying, Yin Zao, Shi Quanxing, Fei Sun · 2018 · Chinese Medical Sciences Journal
  98. Wiek naczyń — u kogo i jak go oceniać? Czy możemy „odmłodzić” naczynia naszych pacjentów?
    Agata Tymińska, Agnieszka Kapłon‐Cieślicka · 2019 · Choroby Serca i Naczyń
  99. Effect on mortality of different routes of administration and loading dose of aspirin in patients with ST-segment elevation acute myocardial infarction treated with primary angioplasty
    Rosario Rossi, Alessandra Bagnacani, Fabio Alfredo Sgura, Daniel Enrique Monopoli, Francesca Coppi, Marisa Talarico, Cristina Rolando, Giuseppe Boriani · 2020 · Coronary Artery Disease
  100. Sekundäre Neuroprotektion beim Glaukom durch ergänzende medikamentöse Therapiekonzepte
    Carl Erb · 2020 · Klinische Monatsblätter für Augenheilkunde